Empowering Patient-Centric Healthcare: EMPE Diagnostics Partners with IHW...

EMPE Diagnostics Clinches Top Honors as #MEA Winner...

Artificial Intelligence: Redefining patient care with improved precision...

Our CEO’s Meeting with WHO Director-General Ignites Passion...

EMPE Diagnostics’ Innovations Spotlighted at ‘Made in Telangana’...

In Quest of Futuristic Diagnostics At the ET...

Dr. Pavan Asalapuram Sets a Global Record for...

Empowering Tomorrow’s Leaders: CEO Raghavendra Goud’s Mentorship for...

EMPE Diagnostics Has Been Nominated for the Swecare...

EMPE Diagnostics Commences Multi-Country Evaluation of mfloDxTM MDR-TB...

Yes, We can end TB! Tuberculosis continues to...

Pioneering Rapid Molecular Test Kits in the Fight...

EMPE Diagnostics Presents at Gates Foundation’s Molecular Diagnostic...

EMPE Diagnostics Exhibits at BioAsia 2023 in Hyderabad...

EMPE Got License to Manufacture Medical Devices We...

EMPE Diagnostics Received a Grant from BMGF

With great immense pleasure He will lead all...

Congratulations on achieving the significant milestones EMPE is...

EMPE is proud to announce that we have...

Another quality stamp for EMPE’s mfloDx™ technology platform and its...

EMPE at the 10-year Indiaspora Global meet Our...

EMPE Recognized for Innovation We are proud and...

EMPE has presented the clinical evaluation results at...

EMPE Diagnostics at the World Economic Forum 2022,...

Secondees from INNOVA4TB at EMPE Diagnostics Liudmyla Dubchak...

EMPE Diagnostics has associated with NIRT, WHO TB...

INNOVA4TB collaborator visited EMPE Diagnostics Olena Rzhepishevska personally...

Christian Medical College (CMC) is an internationally recognized...

The Voice of Secondees – INNOVA4TB Check out...

European Innovation Council grant EMPE Diagnostics has received...

Inauguration of EMPE Diagnostics India On Wednesday March...

SEK 49 million to EMPE Diagnostics with a...

India Sweden Innovation Day 2020 In association with...

Association with WHO TB Supranational Reference Laboratory The...

Changing Worlds Webinar CorkBIC is a private-sector-led organization...

New colleagues EMPE Diagnostics is growing and we...

India-Sweden Year of Health Their Majesties, King Carl...

2019 World Conference on Access to Medical Products...

EMPE Diagnostics hosted students from Uppsala University EMPE...

Presentation of our first product, mfloDx™ mini MDR-TB test...

EMPE Diagnostics presented at Vitalis 2019 We presented...

100 best Nordic Impact Startups EMPE Diagnostics has...

Announcing our first product: mfloDx™  MDR-TB Another great...

INNOVA4TB Kickoff The recently awarded INNOVA4TB project is...

EMPE Diagnostics receives prestigious EU funding Marie Skłodowska-Curie...

EMPE Diagnostics listed on the FIND’s Diagnostics Pipeline...

EMPE presentation at WHO conference! It was a...

We are entering India! Happy to present our...

Catharina Lagerstam is the new Chairman! EMPE is...

Successfully generated Series A investment! We are happy...

EMPE Diagnostics has entered the Swedish Precision Medicine...

Seeking Series A investments! We are going with...

Started clinical validation in Spain! We are happy...

Going to India: Participation in InnoHealth 2017 InnoHEALTH...

Joining the Central Baltic Health Access and Swecare...

EMPE is selected for a round-table discussion at...

Partnering with Q-linea We are happy to announce...

TBnet collaboration EMPE is excited to announce that...

EMPE has received its first collaborative research grant!...

EMPE has appointed its first employee We are...